Argatroban Stroke Treatment - A Pilot Safety Study

NCT00268762 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: argatroban

Sponsor

The University of Texas Health Science Center, Houston